Abstract
S1P1 is an important target from GPCR family, whose crystal structure was released recently. Here, for the first time, we perform the 3D-QSAR analyses on a series of pyrazole oxadiazole derivatives, which are potent S1P1 agonists, by CoMFA and CoMSIA. We use two basic common cores, oxadiazole and pyrazole-oxadiazole, to align all compounds to establish the models of COMFA and COMSIA. The best CoMFA model by applying region focusing achieved a q2 of 0.736 and an r2 of 0.968. The actual predictive capabilities of the best CoMFA and CoMSIA models were then confirmed by the satisfactory predictions for the test set: rpred 2=0.762 for the best CoMFA model. Moreover, the contour maps derived from the best CoMFA and CoMSIA models are consistent with the biological activities of the studied compounds. Our results provide structural details about the interaction between S1P1 and small ligands. Our study is useful in guiding future design of more promising inhibitors of S1P1.
Letters in Drug Design & Discovery
Title:QSAR of Pyrazole Oxadiazole Derivatives as s1p1 Agonists Studied by CoMFA, CoMSIA and Docking
Volume: 10 Issue: 9
Author(s): Baokun Li, Tingjun Hou, Chongqian Zhang and Youyong Li
Affiliation:
Keywords: QSAR, drug design, S1P1, GPCR, CoMFA, CoMSIA.
Abstract: S1P1 is an important target from GPCR family, whose crystal structure was released recently. Here, for the first time, we perform the 3D-QSAR analyses on a series of pyrazole oxadiazole derivatives, which are potent S1P1 agonists, by CoMFA and CoMSIA. We use two basic common cores, oxadiazole and pyrazole-oxadiazole, to align all compounds to establish the models of COMFA and COMSIA. The best CoMFA model by applying region focusing achieved a q2 of 0.736 and an r2 of 0.968. The actual predictive capabilities of the best CoMFA and CoMSIA models were then confirmed by the satisfactory predictions for the test set: rpred 2=0.762 for the best CoMFA model. Moreover, the contour maps derived from the best CoMFA and CoMSIA models are consistent with the biological activities of the studied compounds. Our results provide structural details about the interaction between S1P1 and small ligands. Our study is useful in guiding future design of more promising inhibitors of S1P1.
Export Options
About this article
Cite this article as:
Li Baokun, Hou Tingjun, Zhang Chongqian and Li Youyong, QSAR of Pyrazole Oxadiazole Derivatives as s1p1 Agonists Studied by CoMFA, CoMSIA and Docking, Letters in Drug Design & Discovery 2013; 10 (9) . https://dx.doi.org/10.2174/15701808113109990001
DOI https://dx.doi.org/10.2174/15701808113109990001 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antagonism by Bioactive Polyphenols Against Inflammation: A Systematic View
Inflammation & Allergy - Drug Targets (Discontinued) New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation
Current Vascular Pharmacology Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Current Medicinal Chemistry Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters Recent Advances in Methods of Puerarin Biotransformation
Mini-Reviews in Medicinal Chemistry Management of Unusual Not Scar Ectopic Pregnancy: A Multicentre Retrospective Case Series
Current Women`s Health Reviews Therapeutic Use of MicroRNAs in Cancer
Anti-Cancer Agents in Medicinal Chemistry TNF-α Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets
Current Alzheimer Research Selective Modulation of Aβ42 Production in Alzheimers Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond
Current Pharmaceutical Design The Janus Face of Cathelicidin in Tumorigenesis
Current Medicinal Chemistry Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30
Current Topics in Medicinal Chemistry Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders-Drug Targets Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Current Topics in Medicinal Chemistry Natural Carriers for siRNA Delivery
Current Pharmaceutical Design Imidazoles as Potential Antifungal Agents: A Review
Mini-Reviews in Medicinal Chemistry On the Structural Basis of the Hypertensive Properties of Angiotensin II: A Solved Mystery or a Controversial Issue?
Current Topics in Medicinal Chemistry Oral Insulin: Myth or Reality
Current Diabetes Reviews Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Cardiovascular & Hematological Agents in Medicinal Chemistry Protease-Activated Receptors (PARs) as Therapeutic Targets: Development of Agonists / Antagonists and Modulation of Gastrointestinal Functions
Drug Design Reviews - Online (Discontinued) Mechanistic Insights into the Antileukemic Activity of Hyperforin
Current Cancer Drug Targets